SEC Form 4 · accession 0001209191-17-033415
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
May 16, 2017
Accepted (ET)
May 17, 2017 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 16, 2017 | F | 1,263 | $2.8621 | D | 700,703 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer.
- F2This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David continues to beneficially own or have a right to acquire 1,770,703 shares of common stock.